[K-DOQI guidelines for calcium and phosphorus metabolism in chronic kidney disease: outcomes, compliance and new drugs for treatment].
Negri
A L
AL
D002118:Calcium / Q000378:metabolism*; D000069449:Cinacalcet; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000378:metabolism*; D007811:Lanthanum / Q000627:therapeutic use*; D009281:Naphthalenes / Q000627:therapeutic use*; D010758:Phosphorus / Q000378:metabolism*; D011073:Polyamines / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D000069603:Sevelamer; D016896:Treatment Outcome
D009281:Naphthalenes; D011073:Polyamines; D010758:Phosphorus; C119467:lanthanum carbonate; D007811:Lanthanum; D000069603:Sevelamer; D002118:Calcium; D000069449:Cinacalcet